Cofoe got AG self-test access to EU markets after getting the CE1434 Certificate on 18th May, Cofoe is committed to keep striving to provide high-tech and cost-effective medical products to fight against the pandemic.
The 2019-nCoV antigen test is a novel test that allows rapid detection of unique protein fragments on or within the virus by using a swab to collect a sample from the oral or nasal cavity. So do you know what is the novel coronavirus (2019-nCoV) antigen test kit (colloidal gold method)? Let me tell you more about it!
Cofoe Medical Technology Co.Ltd ( stock symbol:301087) announced on Monday (8th Nov 2021) it has successfully acquired Jerry Medical with 54.0539% share by cash RMB 50,270,162. Jerry Medical is one of the leading power and manual wheelchair manufacturers in China, products were exported to more tha
New Era,new challenge, new opportunity.Cofoe Medical successfully goes public( be listed) with 301087 SZ on 25th October, 2021.It is a great day and big honor for all Cofoe staff and investors.We will constantly strive to serve all the clients around the world, with better products, fuller categorie
There is good news to share with you!In consideration of the fact that the registration of SARS-CoV-2 reagents takes much time and registration fees. In order to support the continuous promotion of SARS-CoV-2 products, the Group has given the following support after discussion : We can provide suppo